Invention Grant
- Patent Title: IL-6 antagonists and uses thereof
-
Application No.: US15880575Application Date: 2018-01-26
-
Publication No.: US11459386B2Publication Date: 2022-10-04
- Inventor: Michael March Schmidt , Thomas M. Barnes , David V. Erbe , Eric Steven Furfine , Alison Tisdale
- Applicant: ELEVEN BIOTHERAPEUTICS, INC.
- Applicant Address: US MA Cambridge
- Assignee: ELEVEN BIOTHERAPEUTICS, INC.
- Current Assignee: ELEVEN BIOTHERAPEUTICS, INC.
- Current Assignee Address: US MA Cambridge
- Agency: McDonnell Boehnen Hulbert & Bergthoff LLP
- Main IPC: C07K16/24
- IPC: C07K16/24 ; A61K39/00
Abstract:
Interleukin-6 (IL-6) antagonists are provided that are specific for binding to site II of IL-6. Methods of using such inhibitors to treat IL-6 related diseases, e.g., disease of the eye such as diabetic macular edema are disclosed.
Public/Granted literature
- US20180222975A1 IL-6 ANTAGONISTS AND USES THEREOF Public/Granted day:2018-08-09
Information query
